OpenVSafe by OpenVAERS
Search V-safe

A3B-78797-38863

2 vaccinations 6 coded responses 19 check-ins 6 free-text entries 5 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
250 / WV
Registered
2020-12-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-25
    Registered in v-safe
  3. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  4. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Itching · Headache
    Adult check-in
  6. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-29
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-05
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-14
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  11. 2021-01-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-16
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  13. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  14. 2021-01-17
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  15. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  16. 2021-01-18
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  17. 2021-01-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  18. 2021-01-21
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  19. 2021-01-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-04
    Survey response — day 21, dose 2
    MedDRA: Depression, Dyspnoea, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Tachycardia 170-180, increases anxiety/depression, shortness of breath sporadically
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-11
    Survey response — day 28, dose 2
    MedDRA: Amnesia, Depression, Dysphemia — Feeling: Fair · Be unable to work
    Free text: Word scrambling and word loss as occurred when I had covid back in nov-dec. stuttering which is also new. Loss of short term memory. Increased anxiety And depression. Reliving work, family and friends deAths from covid.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-02-18
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-02-25
    Survey response — day 42, dose 2
    MedDRA: Abdominal pain lower, Bowel movement irregularity, Fatigue, Haematochezia, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Severe fatigue, · Healthcare visit (other): PCP office for severe llq pain. Ultrasound vaginal and abdominal done. Bowel movements abnormal. No flatus unless supine. Flat stools. BRBPR. Requesting colonoscopy or ex-lap to determine cause.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-02-25
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-04-15
    Survey response — 3 months, dose 2
    MedDRA: Anxiety, Depression, Fatigue, Feeling abnormal, Rash, Sensitive skin, Tachycardia, Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Skin sensitivity, rash/hives coming and going. Brain fog, word salad. Tachycardia out of the blue with no activity. Fatigue. Increased anxiety and depression.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-04-15
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-06-03
  28. 2021-07-15
    Survey response — 6 months, dose 2
    MedDRA: Dyspnoea, Fatigue, Pre-existing disease, Tachycardia, Urticaria — Feeling: Fair
    Free text: Still occurring hives, exhaustion, occasional sob and still having tachycardia since contacting covid. Was never told a time period to wait before vaccination, but have experienced all symptoms since having covid in 11/2020 and vaccination after.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  29. 2021-11-13

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-14Pfizer-BioNTech

Call center

5 call center cases

2 unsuccessful · 3 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-16

Systemic reaction (other): Runny nose

Release 3 — day 21, dose 2

2021-02-04

Symptoms: Tachycardia 170-180, increases anxiety/depression, shortness of breath sporadically

Release 4 — day 28, dose 2

2021-02-11

Symptoms: Word scrambling and word loss as occurred when I had covid back in nov-dec. stuttering which is also new. Loss of short term memory. Increased anxiety And depression. Reliving work, family and friends deAths from covid.

Release 4 — day 42, dose 2

2021-02-25

Symptoms: Severe fatigue,
Healthcare visit (other): PCP office for severe llq pain. Ultrasound vaginal and abdominal done. Bowel movements abnormal. No flatus unless supine. Flat stools. BRBPR. Requesting colonoscopy or ex-lap to determine cause.

Release 7 — 3 months, dose 2

2021-04-15

Symptoms: Skin sensitivity, rash/hives coming and going. Brain fog, word salad. Tachycardia out of the blue with no activity. Fatigue. Increased anxiety and depression.

Release 9 — 6 months, dose 2

2021-07-15

Symptoms: Still occurring hives, exhaustion, occasional sob and still having tachycardia since contacting covid. Was never told a time period to wait before vaccination, but have experienced all symptoms since having covid in 11/2020 and vaccination after.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOAbdominal pain lower ✓ ✓ ✓
HCVOBowel movement irregularity ✓ ✓ ✓
HCVOHaematochezia ✓ ✓ ✓
HCVOOffice visit ✓ ✓ ✓
SDAmnesia ✓ ✓ ✓
SDAnxiety ✓ ✓ ✓
SDDepression ✓ ✓ ✓
SDDysphemia ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDFeeling abnormal ✓ ✓ ✓
SDPre-existing disease ✓ · ✓
SDRash ✓ ✓ ✓
SDSensitive skin ✓ ✓ ✓
SDTachycardia ✓ ✓ ✓
SDUrticaria ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release